Increased conceptual switching by dopaminergic treatment in patients with Parkinson's disease

被引:5
|
作者
Tiedt, Hannes O. [1 ]
Ehlen, Felicitas [1 ,2 ]
Klostermann, Fabian [1 ,3 ]
机构
[1] Charite Univ Med Berlin, Dept Neurol, Motor & Cognit Grp, Campus Benjamin Franklin CBF, Hindenburgdamm 30, D-12203 Berlin, Germany
[2] Jud Krankenhaus Berlin, Dept Psychiat, Heinz Galinski Str 1, D-13347 Berlin, Germany
[3] Humboldt Univ, Berlin Sch Mind & Brain, Unter Linden 6, D-10099 Berlin, Germany
关键词
Parkinson's disease; Verbal fluency; Dopamine; Switches; Cluster; Semantic spreading activation; SPREADING-ACTIVATION THEORY; DEEP BRAIN-STIMULATION; VERBAL FLUENCY; WORKING-MEMORY; COGNITIVE PERFORMANCE; SEMANTIC ACTIVATION; DECISION-MAKING; MODULATION; LEVODOPA; OSCILLATIONS;
D O I
10.1016/j.bandc.2020.105611
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cognitive changes including reduced word production in verbal fluency (VF) tasks are frequently observed in Parkinson's disease (PD) with ambiguous effects of dopaminergic medication on these symptoms. Here, we studied the impact of dopaminergic medication on specific cognitive components underlying VF task performance in 21 participants with PD on their regular medication and following dopamine withdrawal compared with healthy controls. We used temporal cluster analysis (TCA) to differentiate phases of VF output relating to fast automatic lexical activation ('clusters') and slower attention-demanding shifts ('switches'). Dopaminergic medication led to increased switching and, in non-alternating VF tasks, to the formation of smaller and shorter word clusters. The number of switches was correlated with higher cognitive scores and showed an inverse relationship with VF error rates. Increased switching operations during VF task performance can be interpreted in view of nigrostriatal dopaminergic roles for balancing system state versus change propensities. The additional effect on word clustering suggests a modulation of semantic spreading activation mechanisms underlying lexical search, presumably involving non-nigrostriatal, e.g., mesocortical dopaminergic networks.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Initiating dopaminergic treatment in Parkinson's disease
    Lang, Anthony E.
    Marras, Connie
    [J]. LANCET, 2014, 384 (9949): : 1164 - 1166
  • [2] Othello syndrome and chronic dopaminergic treatment in patients with Parkinson's disease
    Kataoka, Hiroshi
    Kiriyama, Takao
    Eura, Nobuyuki
    Sawa, Nobuhiro
    Ueno, Satoshi
    [J]. PARKINSONISM & RELATED DISORDERS, 2014, 20 (03) : 337 - 339
  • [3] Increased energy expenditure may be reversed by dopaminergic medications in patients with Parkinson's disease
    Kashihara, K.
    Hongo, A.
    Kagayama, H.
    Hasegawa, K.
    [J]. MOVEMENT DISORDERS, 2015, 30 : S161 - S162
  • [4] Resting energy expenditure in Parkinson's disease patients under dopaminergic treatment
    Barichella, Michela
    Cereda, Emanuele
    Faierman, Samanta Andrea
    Piuri, Gabriele
    Bolliri, Carlotta
    Ferri, Valentina
    Cassani, Erica
    Vaccarella, Eleonora
    Donnarumma, Ornella Violetta
    Pinelli, Giovanna
    Caronni, Serena
    Pusani, Chiara
    Pezzoli, Gianni
    [J]. NUTRITIONAL NEUROSCIENCE, 2022, 25 (02) : 246 - 255
  • [5] Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment
    Benbir, G.
    Kaynak, D.
    Kiziltan, G.
    Kaynak, H.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 19 - 20
  • [6] Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment
    Kaynak, D
    Kiziltan, G
    Kaynak, H
    Benbir, G
    Uysal, O
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 (03) : 199 - 207
  • [7] Dopaminergic agonists in the treatment of Parkinson's disease: A review
    Piccoli, F
    Riuggeri, RM
    [J]. JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1995, (45): : 187 - 195
  • [8] Continuous dopaminergic stimulation in Parkinson's disease treatment
    Stocchi, F
    [J]. NEUROLOGIA, 2002, 17 : 62 - 65
  • [9] Switching from selegiline to rasagiline treatment in patients with Parkinson's disease
    Marti Masso, J. F.
    Bolano, M. J.
    Ruiz Martinez, J.
    [J]. MOVEMENT DISORDERS, 2008, 23 (01) : S309 - S309
  • [10] Anxiety and dopaminergic stimulation in patients with Parkinson's disease
    Camacho Nieto, A.
    Franco Salinas, A. R.
    Ruiz-Escribano Menchen, L.
    Gallardo Alcaniz, M. J.
    Cabello Rosa, J. P.
    Vaamonde Gamo, J.
    [J]. MOVEMENT DISORDERS, 2019, 34 : S627 - S627